Becton, Dickinson and Company Debt Securities Underwriting AgreementUnderwriting Agreement • August 13th, 2021 • Becton Dickinson & Co • Surgical & medical instruments & apparatus • New York
Becton Dickinson and Company, a New Jersey corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) €400,000,000 principal amount of its 0.000% Notes due 2023 (the “2023 Notes”) and (ii) €500,000,000 principal amount of its 0.034% Notes due 2025 (the “2025 Notes” and, together with the 2023 Notes, the “Securities”). The Securities are to be issued pursuant to the Indenture, dated as of March 1, 1997 (the “Base Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A.), as trustee (the “Trustee”) (the “Indenture”).
Becton Dickinson Euro Finance S.à r.l. as issuer Becton, Dickinson and Company as guarantor Debt Securities Underwriting AgreementUnderwriting Agreement • August 13th, 2021 • Becton Dickinson & Co • Surgical & medical instruments & apparatus • New York
Becton Dickinson Euro Finance S.à r.l., a Luxembourg private limited liability company (société à responsabilité limitée) having its registered office at L-1471 Luxembourg, 412 F, route d’Esch and registered with the Luxembourg trade and companies register (Registre de commerce et des sociétés, Luxembourg) under number B234229 (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) €900,000,000 principal amount of its 0.334% Notes due 2028 (the “2028 Notes”) and (ii) €900,000,000 principal amount of its 1.336% Notes due 2041 (the “2041 Notes” and, together with the 2028 Notes, the “Securities”). The Securities will be fully and unconditionally guaranteed as to payment of principal, premium, if any, and interest (the “Guarantees”) by Becton, Dickinson and Company, a New Jersey corporation (the “Guarantor”) and the indirect parent of the Company. The Securities a
as Issuer BECTON, DICKINSON AND COMPANY as Guarantor AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of August 13, 2021 0.334% Notes due 2028 1.336% Notes due 2041Third Supplemental Indenture • August 13th, 2021 • Becton Dickinson & Co • Surgical & medical instruments & apparatus • New York
THIRD SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of August 13, 2021, among Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 412 F route d’Esch, L-1471 Luxembourg and registered with the Luxembourg Trade and Companies Register under number B234229 (the “Company”), Becton, Dickinson and Company, a New Jersey corporation (the “Guarantor”), and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”).
